Skip to main content
Clinical Hub · Metabolic Peels

Metabolic Peels

Metabolic peels versus traditional chemical peels: biological regulation instead of chemical injury
From chemical injury to biological regulation: metabolic peels challenge the idea that visible desquamation is required to achieve meaningful clinical activity.

Metabolic peels are not designed to act only through superficial exfoliation. They are conceived to modulate biological skin activity, influence regeneration pathways, and support a more functional form of corrective skin management.

Unlike conventional peel logic focused mainly on visible desquamation, this category addresses cellular behaviour, pigment dynamics, skin fatigue, recovery capacity, and long-term tissue regulation. In practical use, metabolic peels are often integrated where the skin requires guidance, rebalancing, and progressive correction rather than simple surface aggression.

  • Complex or recurrent dyschromia
  • Biologically fatigued or chronically stressed skin
  • Post-inflammatory or post-procedural recovery support
  • Long-term maintenance after corrective protocols

A Different Clinical Philosophy

This hub gathers the metabolic solutions portfolio, its clinical rationale, related protocol pathways, and the core scientific positioning behind this category.

Functional Skin Reprogramming Low Surface Aggression Protocol Integration
This category is not defined by stronger injury, but by better biological control.
Explore the Science View Protocol Logic

Clinical Overview

Clinical Positioning
Why Metabolic Peels Are Different
Solutions Portfolio
Clinical Use Pathways
Risk of Classical Peels
Clinical Navigation
FAQ
Strategic Clinical Summary
Scientific Positioning
Clinical School Positioning
Acid Classification Model
Section 2 · Clinical Positioning

Where Metabolic Peels Stand Clinically

Metabolic peels occupy a distinct place within chemical peeling strategy. They should not be understood as a simple variation of superficial peeling, but as a category designed to support functional skin correction, biological modulation, and progressive tissue rebalancing.

Beyond Pure Exfoliation

In conventional peel thinking, the clinical objective is often reduced to visible exfoliation, controlled injury, or accelerated epidermal turnover. Metabolic peels follow a broader rationale. Their role is not limited to removing superficial layers, but to influence the biological environment in which the skin recovers, reorganises, and stabilises itself over time.

This is precisely why they become relevant in situations where the practitioner is not merely seeking a stronger peel, but a more intelligent response from the skin: better tolerance, improved recovery logic, more coherent maintenance, and a clinically useful bridge between correction and long-term regulation.

Conventional Peel Logic
  • Often centred on exfoliation intensity
  • Primarily judged by visible peeling or frosting effect
  • Shorter corrective focus
  • More surface-driven endpoint reading
Metabolic Peel Logic
  • Centred on biological guidance and tissue behaviour
  • Designed to support repair, regulation, and functional balance
  • Useful in maintenance, transition, and recovery phases
  • Less dependent on visible aggression alone

From Technique to Strategy

The real clinical shift is not about choosing a different peel, but about redefining the objective of treatment.

Instead of asking how strong a peel should be, the more relevant question becomes: what biological response are we trying to guide?

This is where metabolic logic moves beyond product selection and becomes a strategy of skin management, integrating correction, tolerance, and long-term coherence.

A Category for Complex Skin Management

Metabolic peels are especially relevant when the skin no longer behaves like a simple healthy substrate ready for routine exfoliation. In real practice, many patients present with fatigued skin dynamics, recurrent dyschromia, post-inflammatory instability, barrier stress, or incomplete recovery after previous interventions.

In such contexts, the therapeutic challenge is not always to peel more aggressively, but to restore a more coherent biological response. This is where metabolic solutions become clinically valuable: they help reposition the practitioner from a purely abrasive logic toward a more strategic logic of support, modulation, and controlled progression.

Core Clinical Pillars

Biological Modulation

Support of pathways involved in regeneration, repair, pigment behaviour, and tissue adaptation.

Functional Correction

Useful when the goal is not only cosmetic resurfacing, but progressive rebalancing of skin function.

Protocol Integration

Particularly relevant before, between, or after stronger corrective interventions as part of a broader plan.

Lower Surface Aggression

A category designed to work with less dependence on visible epidermal violence when properly selected.

Clinical meaning: metabolic peels should be viewed as a strategic category for practitioners who want to move from a peel-only mindset toward a more advanced form of skin management integrating correction, recovery, maintenance, and biological coherence.
Skin complications risk during desquamation phase after chemical peel showing corneocyte disruption and increased penetration
Most complications occur when the patient is unsupervised — at peak desquamation.

Its Place on ChemicalPeeling.com

On this platform, the metabolic peel category stands between pure product presentation and protocol intelligence. It connects science, formulation logic, clinical use pathways, and practical integration.

In other words, this hub is not just a catalogue page. It is the point where the practitioner can understand why these products exist, when they become clinically relevant, and how they relate to broader corrective protocols across the site.

Section 3 · Biological Targeting

Why Metabolic Peels Are Different

The distinction between metabolic and standard peels is not based solely on chemistry. It is based on how the skin is approached as a biological system, and how treatment strategies are designed to influence its behaviour at different epidermal levels.

Metabolic peels mechanism targeting the stratum basale with controlled surface flaking and trans-epidermal diffusion
Key interpretation: visible flaking may be used as a surface response, but the primary biological objective of metabolic logic is the regulation of living epidermal structures, especially at the basal level.

Biological Targeting Matters

Conventional peels are frequently judged by what happens at the surface. Metabolic peels introduce a more sophisticated view: surface visibility, tissue transit, and true biological target are not the same thing.

This distinction is clinically decisive. A patient may see flaking, but the therapeutic rationale may actually depend on what is happening deeper, where renewal, regulation, and tissue adaptation are coordinated.

  • Controlled flaking may provide visible feedback without defining therapeutic depth.
  • Active diffusion through viable epidermis is a pathway, not the final endpoint.
  • The true metabolic target lies in the living epidermal compartment, especially the basal layer.

From Injury to Regulation

Standard peels are often built on a logic of controlled injury followed by repair. Metabolic peels introduce a different approach: supporting biological regulation before forcing visible damage.

From Surface to Function

Instead of focusing only on the stratum corneum, metabolic strategies aim to influence living epidermal layers, cellular turnover, and functional balance.

From Intensity to Intelligence

Clinical outcomes are not only determined by strength or concentration. They depend on protocol design, sequencing, and biological coherence.

Visible vs Functional Activity

A peel does not need to produce broad desquamation to be active. Visible surface response and meaningful biological action are not equivalent phenomena.

Tolerance and Repeatability

Metabolic peels are often integrated where repeated sessions are needed, allowing progressive correction with lower inflammatory burden.

Protocol-Centered Thinking

The key is not choosing a stronger peel, but building a coherent treatment sequence adapted to the indication and the patient.

A chemical peel is not defined by how much the skin peels, but by how intelligently the skin is guided.

Metabolic peels are not weaker — they are more controlled.

Functional Acid Model — Ionization & Skin Diffusion

SCIENTIFIC INTERPRETATION

X-axis: pH (chemical environment)
Skin ≈ pH 5.5

Y-axis: % unionized
Determines diffusion capacity

Higher unionized fraction → higher penetration

Only the non-ionized form crosses biological membranes

METABOLIC ZONE
INJURY ZONE
Depth ≠ Function
Function = Biological Outcome
Section 4 · Metabolic Solutions Portfolio

Metabolic Solutions Portfolio

This portfolio should not be read as a simple product list. It reflects a structured clinical ecosystem designed for biological modulation, progressive correction, support phases, protocol sequencing, and indication-specific use.

Comparison between metabolic peels and standard chemical peels showing stimulation of the basal layer versus surface exfoliation
Clinical comparison: metabolic peels are built around biological stimulation and regulation, whereas standard chemical peels act primarily through controlled surface injury and exfoliation.

Why This Comparison Matters

Not all peeling strategies pursue the same objective. This distinction is essential because surface exfoliation, tissue stimulation, and biological targeting are not equivalent therapeutic logics.

The metabolic portfolio is designed for clinical environments where the practitioner wants more than a visible peel: better coherence, greater control, improved tolerance, and a more functional relationship with skin renewal.

  • Metabolic peels are centred on stimulation, regulation, and living epidermal targets.
  • Standard chemical peels are centred on exfoliation and surface-oriented chemical action.
  • The portfolio below should therefore be read as a system of clinical tools, not as interchangeable surface peels.
  • Metabolic peels are centred on stimulation, regulation, and living epidermal targets.
  • Standard chemical peels are centred on exfoliation and surface-oriented chemical action.
  • The portfolio below should therefore be read as a system of clinical tools, not as interchangeable surface peels.

In practical portfolio interpretation, Peeling de Luxe Plus functions as the core metabolic peel, aligned with retinoic acid–driven renewal and living epidermal targeting. Within more advanced sequence-based strategies, Lipoic Acid may serve as a diffusion-support step, contributing to trans-epidermal penetration and functional modulation.

1. Core Metabolic Peels

These formulations represent the central metabolic logic of the category and form the backbone of advanced treatment design.

Peeling de Luxe Plus
Core

Peeling de Luxe Plus

Central metabolic formulation used in advanced protocols for modulation, transition phases, and broader corrective design.

View Product
Gradient Cream
Core

Gradient Cream

Progressive modulation support designed for tolerance management, sequence control, and long-term clinical coherence.

View Product
Stretchpeel
Core

Stretchpeel

Targeted metabolic support often positioned in dyschromia-oriented and lower-trauma treatment strategies.

View Product

2. Support & Modulation

These products support renewal quality, modulation, pigment-oriented care, tolerance, and maintenance phases within the metabolic framework.

Lipoic Acid
Support

Lipoic Acid

Antioxidant-driven support used in skin regulation strategies where biological balance and controlled progression matter.

View Product
Papaya Cream
Support

Papaya Cream

Enzymatic support solution for gentle renewal, maintenance logic, and biologically guided skin activity.

View Product
Clarté de Lune
Pigment Support

Clarté de Lune

Metabolic support product positioned around radiance, pigment-oriented care, and controlled corrective pathways.

View Product
Rose du Désert
Support

Rose du Désert

Support and modulation solution positioned for balance, maintenance, and biologically coherent protocol integration.

View Product

3. Protocol Environment

These formulations support the treatment environment before, during, or after intervention and contribute to broader protocol architecture.

PrePeel
Protocol Support

PrePeel

Designed for pre-procedural preparation and improved protocol readiness within a controlled clinical workflow.

View Product
PostPeel
Protocol Support

PostPeel

Post-procedural support formulation contributing to recovery logic, tolerance, and maintenance of protocol coherence.

View Product
Kosmopeel
Protocol Support

Kosmopeel

Integrated protocol product positioned within the broader metabolic environment rather than as an isolated intervention.

View Product
Ormes des Sioux
Protocol Support

Ormes des Sioux

Supportive formulation integrated into protocol design where progression, environment, and sequence intelligence matter.

View Product

4. Specific Indications

These products address more targeted zones or indication-specific positioning within the broader metabolic portfolio.

Eye Contour Gel
Specific Indication

Eye Contour Gel

Indication-focused product designed for the delicate periorbital area and specific functional skin support needs.

View Product
Les Félins
Specific Indication

Les Félins

More specialised positioning within the metabolic range, suited to targeted aesthetic logic and selective protocol use.

View Product

From Portfolio to Protocol Intelligence

These formulations are most valuable when understood as part of a structured therapeutic logic. Explore how metabolic solutions connect with broader clinical pathways, sequencing strategies, and decision-making principles.

Explore Clinical Protocols Read the Core Science
Section 5 · Clinical Use Pathways

Clinical Use Pathways

Metabolic solutions are not used randomly. Their value lies in how they are integrated into clinical strategies, depending on the indication, skin behavior, and treatment objective.

Metabolic peels protocol showing stimulation of the basal layer with Peeling de Luxe Plus, controlled surface flaking with 30 Min Peel Off, and trans-epidermal diffusion with Lipoic Acid
Protocol logic: this sequence combines basal stimulation, controlled surface flaking, and trans-epidermal diffusion support as coordinated functions within one biologically guided metabolic protocol.

From Products to Sequence Logic

A metabolic protocol should not be interpreted as a simple accumulation of products. Its value lies in how distinct biological functions are sequenced to create a more controlled and coherent clinical response.

In this framework, Peeling de Luxe Plus supports basal stimulation, 30 Min Peel Off provides a controlled visible flaking step, and Lipoic Acid contributes to penetration-support and functional modulation.

  • Stimulate = activation of living epidermal renewal logic.
  • Controlled surface flaking = visible response when clinically useful, without defining the primary biological target.
  • Penetrate = enhanced trans-epidermal diffusion within sequence-based strategy.
Regulation & Maintenance
Used when the goal is to stabilize skin function, improve tolerance, and maintain results over time.
  • Post-procedure recovery phases
  • Sensitive or reactive skin
  • Long-term pigment control
  • Maintenance after correction
Correction & Active Treatment
Integrated into active protocols where visible correction is required, often in combination with standard peels.
  • Dyschromia and melasma
  • Acne and seborrheic skin
  • Photoaging and texture
  • Controlled resurfacing strategies
Sequencing Strategy
The most advanced use of metabolic peels is within sequence-based protocols, where each step has a specific role.
  • Stimulate → metabolic activation
  • Controlled surface flaking → visible but secondary step
  • Modulate → recovery and coherence
  • Repeat → progressive improvement

The question is not which peel is stronger, but which biological strategy is appropriate.

Metabolic peels are not an alternative — they are a framework for smarter clinical design.

Section 5.5 · Critical Risk Window

Where Most Complications Actually Occur

In classical peeling, the most problematic moment is not always the procedure itself. Very often, the real danger appears later — when the patient enters the desquamation phase without supervision, while the barrier is unstable and the biological cost of error becomes much higher.

Risk of complications during the desquamation phase after a classical chemical peel with increased penetration and unstable skin barrier
Critical interpretation: once corneocyte cohesion is lost, external penetration increases and the patient may face the highest complication risk precisely when no operator is present.

The Problem Is Often the Unsupervised Window

During visible desquamation, the skin may no longer behave like a stable barrier. At that moment, compliance errors, inappropriate products, friction, sun exposure, self-manipulation, or poorly understood aftercare can become far more consequential.

Most complications do not occur during the procedure — they occur when the patient is alone, at peak desquamation.
  • Barrier instability may amplify the effect of external irritants and uncontrolled topical exposure.
  • Visible peeling can create a false sense of “normal process” while biological vulnerability is actually increasing.
  • The danger is not only chemical intensity, but the mismatch between tissue state and patient behaviour.

Why This Matters Clinically

A peeling strategy should not be judged only by what happens in-office. It must also be judged by what happens after the patient leaves — especially during the phase when tissue control decreases and complication potential rises.

Why Metabolic Logic Changes the Equation

This is precisely where metabolic strategies redefine safety: less dependence on broad desquamation, more emphasis on biological control, tolerance, and guided regulation. In other words, safety is no longer reduced to depth alone — it becomes a question of systemic coherence.

Clinical Questions Physicians Actually Ask

Are metabolic peels weaker than traditional chemical peels?
No. They are not weaker — they are more controlled.

Traditional peels often rely on visible aggression (frosting, desquamation), while metabolic peels focus on biological regulation of the epidermis.
Why do complications occur after aggressive peeling?
Complications are not caused by the acid itself, but by loss of epidermal control and barrier disruption.

Once corneocyte cohesion is altered, the skin enters an inflammatory cascade rather than a regenerative process.
Can metabolic peels reverse post-inflammatory hyperpigmentation?
Yes — when used within a structured protocol.

The goal is not exfoliation, but restoration of biological control, allowing progressive normalization of melanocyte activity.
Should visible peeling (desquamation) be considered a success?
Not necessarily.

Desquamation is a side effect, not a therapeutic objective.

The real endpoint is controlled regeneration — not visible skin shedding.
How do I integrate metabolic peels into my practice?
Metabolic peels are not used alone — they are integrated into sequence-based protocols combining stimulation, modulation, and controlled surface response.

This requires understanding clinical timing and biological logic.

Strategic Clinical Summary

Chemical peeling should not be understood as a technique of aggression, but as a method of biological guidance.

Traditional approaches focus on visible skin reaction: frosting, desquamation, inflammation.

But these are consequences — not objectives.

The real target is not the surface.
It is the biological control of the epidermis.

When epidermal regulation is preserved, the skin regenerates.
When it is disrupted, complications appear: hyperpigmentation, inflammation, instability.

Metabolic peels redefine the objective:
not to force peeling — but to guide cellular behavior.

Stop treating the consequence. Control the process.

Scientific Positioning

The classical classification of chemical peels is primarily based on depth of injury and visible skin response. This framework assumes that clinical efficacy is directly linked to the intensity of epidermal damage.

However, emerging observations suggest that outcomes are not determined by the extent of surface injury, but by the preservation or disruption of epidermal regulatory mechanisms.

Clinical outcomes are governed by biological control — not by visible aggression.

Within this perspective, metabolic peels introduce a different paradigm: they aim to interact with living epidermal layers, modulate cellular turnover, and maintain functional integrity, rather than inducing uncontrolled desquamation.

  • Shift from depth-based classification to function-based understanding
  • Focus on basal layer activity rather than surface destruction
  • Reduction of inflammatory cascade and post-procedural instability
  • Integration into sequence-based therapeutic strategies

This conceptual shift aligns with a broader movement in dermatology: transitioning from injury-driven intervention to biologically guided modulation.

The objective is no longer to produce a visible peel, but to restore predictable and controlled epidermal behavior.
This is not a variation of peeling. It is a change of paradigm.

Clinical School Positioning

Classical Chemical Peels
Based on a model of controlled injury, where clinical outcomes depend on the intensity of epidermal damage.
  • Depth-based classification
  • Frosting and desquamation as endpoints
  • Inflammation-driven regeneration
  • Higher risk of dysregulation
Tiziani Approach
Introduces technical modulation of penetration depth through application dynamics and pressure control.
  • Application pressure influences depth
  • Same product, variable penetration
  • Improved control vs classical approach
  • Still surface-oriented mechanism
Tenenbaum Metabolic Model
Redefines peeling as a process of biological regulation rather than surface destruction.
  • Primary target: basal layer
  • Retinoic acid-driven stimulation
  • Controlled flaking (optional, not endpoint)
  • Trans-epidermal diffusion strategy
From injury-based peeling to controlled biological modulation

Tenenbaum Functional Acid Classification Model

Chemical peels cannot be understood through depth alone. A functional classification requires integration of chemical structure, functional behavior, and biological role.

Acid pKa Type Function Biological Role
TCA Very Low Monoprotic Caustic Surface Injury
Glycolic Acid ~3.8 Monoprotic Keratolytic Surface Renewal
Salicylic Acid ~2.9 Monoprotic Lipophilic / Comedolytic Sebum Targeting
Citric Acid Multiple Triprotic Hydrating / Buffering Metabolic Regulation
Retinoic Acid N/A Non-classical Cell Signaling Basal Stimulation
Chemical Axis
pKa, proticity, and molecular structure determine acid potential.
Functional Axis
Acids exhibit distinct behaviors: keratolytic, hydrating, or modulatory.
Biological Axis
The true relevance lies in biological response: injury vs metabolic control.
From chemical classification to biological function-driven strategy

Share this website on your social medias